Analysis of biological activities of recombinant rat interleukin-5

International Archives of Allergy and Immunology

Volumn 120, Issue SUPPL. 1, 1999, Pages 11-14

  Ishihara, Kenji ^a   Nittoh, Takeaki ^a   Satoh, Ikuko ^a   Ohuchi, Kazuo ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

B cell growth factor II; Eosinophil differentiation factor; Eosinophil survival enhancing factor; Interleukin 5

Indexed keywords

METHYLCELLULOSE; NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY; RECOMBINANT INTERLEUKIN 5;

BONE MARROW CELL; CELL PROLIFERATION; COLONY FORMATION; CONFERENCE PAPER; EOSINOPHIL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; B-LYMPHOCYTES; CELL DIVISION; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; INTERLEUKIN-5; RATS; RECOMBINANT PROTEINS;

EID: 0032885381     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000053585     Document Type: Conference Paper

References (21)

1. Azuma C, Tanabe T, Konishi M, Kinashi T, Noma T, Matsuda F, Yaoita Y, Takatsu K, Hammarström L, Smith CIE, Severinson E, Honjo T: Cloning of cDNA for human T-cell replacing factor (interleukin-5) and comparison with the murine homologue. Nucleic Acids Res 1986;14:9149-9158.
2. Kinashi T, Harada N, Severinson E, Tanabe T, Sideras P, Konishi M, Azuma C, Tominaga A, Bergstedt-Lindqvist S, Takahashi M, Matsuda F, Yaoita Y, Takatsu K, Honjo T: Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II. Nature 1986;324:70-73.
3. Proudfoot AEI, Fattah D, Kawashima EH, Bernard A, Wingfield PT: Preparation and characterization of human interleukin-5 expressed in recombinant Escherichia coli. Biochem J 1990;270:357-361.
4. Kunimoto DY, Allison KC, Watson C, Fuerst T, Armstrong GD, Paul W, Strober W: High-level production of murine interleukin-5 (IL-5) utilizing recombinant baculovirus expression. Purification of the rIL-5 and its use assessing the biologic role of IL-5 glycosylation. Cytokine 1991;3:224-230.
5. Koike M, Takatsu K: IL-5 and its receptor: Which role do they play in the immune response? Int Arch Allergy Immunol 1994;104: 1-9.
6. Kitagaki K, Niwa S, Hoshiko K, Nagai H, Hayashi S, Totsuka T: Augmentation of apoptosis in bronchial exuded rat eosinophils by cyclosporin A. Biochem Biophys Res Commun 1996;222:71-77.
7. Haczku A, Macary P, Haddad E-B, Huang TJ, Kemeny DM, Moqbel R, Chung KF: Expression of Th-2 cytokines interleukin-4 and -5 and of Th-1 cytokine interferon-γ in ovalbumin-exposed sensitized Brown-Norway rats. Immunology 1996;88:247-251.
8. Nittoh T, Arii M, Suzuki R, Kitoh A, Watanabe M, Mue S, Ohuchi K: Increase in eosinophilic cell population in bone marrow of rats by immunization with Ascaris suum antigen. Immunol Invest 1997;26:439-451.
9. Underwood SL, Raeburn D, Lawrence C, Foster M, Webber S, Karlsson J-A: RPR 106541, a novel, airways-selective glucocorticoid: Effects against antigen-induced CD4+T lymphocyte accumulation and cytokine gene expression in the Brown Norway rat lung. Brit J Pharmacol 1997;122:439-446.
10. Ishihara K, Satoh I, Nittoh T, Kanaya T, Okazaki H, Suzuki T, Koyama T, Sakamoto T, Ide T, Ohuchi K: Preparation of recombinant rat interleukin-5 by baculovirus expression system and analysis of its biological activities. Biochim Biophys Acta 1999; in press.
11. Mita S, Tominaga A, Hitoshi Y, Sakamoto K, Honjo T, Akagi M, Kikuchi Y, Yamaguchi N, Takatsu K: Characterization of high-affinity receptors for interleukin 5 on interleukin 5-dependent cell lines. Proc Natl Acad Sci USA 1989;86:2311-2315.
12. Tominaga A, Mita S, Kikuchi Y, Hitoshi Y, Takatsu K, Nishikawa S, Ogawa M: Establishment of IL-5-dependent early B cell lines by long-term bone marrow cultures. Growth Factors 1989;1:135-146.
13. Kobayashi Y, Saheki T, Shinozawa T: Induction of PC 12 cell death, apoptosis, by a sialoglycopeptide from bovine brain. Biochem Biophys Res Commun 1994;203:1554-1559.
14. Yamaguchi Y, Suda T, Suda J, Eguchi M, Miura Y, Harada N, Tominaga A, Takatsu K: Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J Exp Med 1988;167:43-56.
15. Watanabe M, Nittoh T, Suzuki T, Kitoh A, Mue S, Ohuchi K: Isolation and partial characterization of eosinophil granule proteins in rats - Eosinophil cationic protein and major basic protein. Int Arch Allergy Immunol 1995; 108:11-18.
16. Überia K, Li W, Qin Z, Richter G, Raabe T, Diamantstein T, Blankenstein T: The rat interleukin-5 gene: Characterization and expression by retroviral gene transfer and polymerase chain reaction. Cytokine 1991;3:72-81.
17. Yamaguchi Y, Hayashi Y, Sugama Y, Miura Y, Kasahara T, Kitamura S, Torisu M, Mita S, Tominaga A, Takatsu K, Suda T: Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med 1988;167:1737-1742.
18. Yamaguchi Y, Suda T, Ohta S, Tominaga K, Miura Y, Kasahara T: Analysis of the survival of mature human eosinophils: Interleukin-5 prevents apoptosis in mature human eosinophils. Blood 1991;78:2542-2547.
19. Bousquet S, Chanez P, Lacoste JY, Barnéon G, Ghanavian N, Enander I, Venge P, Ahlstedt S, Simony-Lafontaine J, Godard P, Michel F-B: Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033-1039.
20. Corrigan CJ, Kay AB: T cells and eosinophils in the pathogenesis of asthma. Immunol Today 1992;13:501-507.
21. Leung DYM: Atopic dermatitis: The skin as a window into the pathogenesis of chronic allergic disease. J Allergy Clin Immunol 1995;96: 302-319.